1Glass PS, Hardman D, Kamiyama Y, et al. Preliminary pharmaco-kinetics and pharmacodynamics of an ultra-short-acting opioid :remifentanil(G187084B). Anesth Analg, 1993, 77: 1031-1040.
2Pasero CL, MeCaffery M. Avoiding opioid-induced respiratory depression. Am J Nurs, 1994, 94: 24-30.
3Bouillon T, Bruhn J, Radu Radulescu L, et al. A model of the ventilatory depressant potency of remifentanil in the non-steady state.Anesthesiology, 2003, 99 : 779-787.
4Monk JP, Beresford R, Ward A. Sufentanil. A review of its pharmacological properties and therapeutic use. Drugs, 1988, 36: 286-313.
5Freye E, Lataseh L, Portoghese PS. The delta receptor is involved in sufentanil-induced respiratory depression-opioid subreceptors mediate different effects. Eur J Anaesthesiol, 1992, 9: 457-462.
6Ishiyama T, Kashimoto S, Oquchi T, et al. Epidural ropivacaine anesthesia decreases the bispectral index during the awake phase and sevoflurane general anesthesia. Anesth Analg, 2005, 100: 728-732.
7Gentili M, Huu PC, Enel D, et al. Sedation depends on the level of sensory block induced by spinal anaesthesia. Br J Anaesth, 1998, 81 :970-971.
8Borgbjerg FM, Nielsen K. Franks J. Experimental pain stimulates respiration and attenuates morphine-induced respiratory depression: a controlled study in human volunteers. Pain, 1996, 64: 123-128.
9Egan TD, Minto CF, Hermann DJ, et al. Remifentanil versus alfentanil: comparative pharmacokinetics and pharmacodynamics in healthy adult male volunteers. Anesthesiology, 1996, 84: 821-833.
10Rose DK,Cohen MM.The airway:problems and predictions in 18,500 patients.Can J Anaesth,1994,41:372-383.
4Puchner W, Obwegeser J, Puhringer FK. Use of remifentanil for a- wake fiberoptic intubation in a morbidly obese patient with severe in- flammation of the neck [ J ]. Acta Anaesthesiol Scand, 2002,46 (4) :473-476.
5Reusche MD, Egan TD. Remifentanil for conscious sedation and an- algesia during awake fiberoptic tracheal intubation: a case report with pharmacokinetic simulations[ J]. J Clin Anesth, 1999,11 ( 1 ) :64-68.
6Chernik DA, Gillings D, Laine H, et al. Validity and reliability of the Observer' s Assessment of Alertness/Sedation Scale: study with intravenous midazolam [ .1 ]. J Clin Psychopharmacol, 1990, 10 (4) :244-251.
7Viby-Mogensen J, Engbaek J, Eriksson L1, et al. Good clinicalre- search practice (GCRP) in pharmacodynamic studies of neuromus- cular blocking agents [ J ]. Acta Anaesthesiol Scand, 1996,40 ( 1 ) :59-74.
8Randell T, Valli H, Lindgren L. Effeets of alfentanil on the re- sponses to awake fiberoptic nasotraeheal intubation [ J ]. Acta An- aesthesiol Seand, 1990,34( 1 ) :59-62.
9Andel H, Klune G, Andel D, et al. Propofol without muscle relax- ants for conventional or fiberoptic nasotracheal intubation: a dose- finding study[J]. Anesth Analg, 2000,91(2) :458-461.
10?~eed AP. Preparation for intubation of the awake patient [ J ]. Mt Sinai J Med, 1995,62 ( 1 ) : 10-20.
